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Background: HIV epidemiology and intervention uptake among
female sex workers (FSW) in sub-Saharan Africa remain poorly
understood. Data from outreach programs are a neglected resource.
Methods: Analysis of data from FSW consultations with
Zimbabwe’s National Sex Work program, 2009–2014. At each visit,
data were collected on sociodemographic characteristics, HIV testing
history, HIV tests conducted by the program and antiretroviral
(ARV) history. Characteristics at ﬁrst visit and longitudinal data on
program engagement, repeat HIV testing, and HIV seroconversion
were analyzed using a cohort approach.
Results: Data were available for 13,360 women, 31,389 visits,
14,579 reported HIV tests, 2750 tests undertaken by the program,
and 2387 reported ARV treatment initiations. At ﬁrst visit, 72% of
FSW had tested for HIV; 50% of these reported being HIV positive.
Among HIV-positive women, 41% reported being on ARV. 56% of
FSW attended the program only once. FSW who had not previously
had an HIV-positive test had been tested within the last 6 months
27% of the time during follow-up. After testing HIV positive,
women started on ARV at a rate of 23/100 person years of follow-up.
Among those with 2 or more HIV tests, the HIV seroconversion rate
was 9.8/100 person years of follow-up (95% conﬁdence interval: 7.1
to 15.9).
Conclusions: Individual-level outreach program data can be used
to estimate HIV incidence and intervention uptake among FSW in
Zimbabwe. Current data suggest very high HIV prevalence and
incidence among this group and help identify areas for program
improvement. Further methodological validation is required.
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KEY MESSAGES
• Although there are a range of approaches to surveillance
HIV among high-risk, marginalized groups such as female
sex workers (FSW) in sub-Saharan Africa, these all have
limitations and there remains a highly damaging paucity of
data from these populations to guide public health action
• Data collected through outreach programs that provide
services to female sex workers are a potentially valuable
but neglected resource.
• We developed a cohort analysis approach to estimating
HIV incidence and intervention uptake among female sex
workers using data from over 31,000 outreach program
contacts with 13,000 women in 26 sites covering all
provinces in Zimbabwe, 2009–2014.
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• The data suggest very high incidence (10%–12% per year)
among female sex workers in Zimbabwe and suggest
program retention, repeat HIV testing, and linkage to
treatment can all be improved. The analysis approach
could be used to track whether improvements are being
realized over time.
• The approach has many potential biases, but these are
worthy of better characterization through further study
characterization because all feasible approaches to surveil-
lance among this group are ﬂawed and data triangulation
is needed.
INTRODUCTION
Tracking HIV epidemiology and intervention uptake
among populations at high risk of infection is essential. One
such group are female sex workers (FSW) in sub-Saharan
Africa.1 Sex work-related behaviors are illegal and/or stigma-
tized in many countries, including Zimbabwe.2,3 Sex workers
in Zimbabwe most commonly solicit clients in bars, start sex
work at 22–23 years of age, and report 2 clients per week.
Many experience violence in their work, whereas 65%–73%
report consistent condom use with transactional partners.4
General population surveys that ask about these
behaviors suffer from social desirability bias and anyway
tend to recruit few individuals in these risk categories. The
major issue for surveys of this hidden population is that no
sampling frame for the target population is available.
Location-based5 or respondent-driven sampling (RDS) sur-
veys6,7 that target FSW improve signiﬁcantly upon conve-
nience samples and are theoretically based and feasible, but
remain complex to analyze and interpret. Structural factors,
including high mobility, further complicate matters.8,9 A
signiﬁcant information gap therefore remains, which prevents
better programming for FSW in Africa. A recent systematic
review of HIV epidemiology among FSW identiﬁed 30 HIV
prevalence studies (16 countries; average sample size, 714
women) but no HIV incidence studies from sub-Saharan
Africa since 2007.1 Another review identiﬁed only 7 African
studies in 5 countries on ARV uptake, attrition, adherence,
and outcomes among FSW.10
Data from outreach programs are a potential resource.
We compiled individual-level programmatic data collected
from consultations with the Zimbabwean national HIV pre-
vention program for FSW from 2009 to 2014. Using cohort
methods, we estimated intervention uptake and, among FSW
with serial HIV tests, the rate of HIV seroconversion. The aim
of this paper is not to evaluate the program; rather, we
describe our analysis of the data, interpret the indicators
we develop, and consider strengths and limitations of
our approach.
METHODS
Setting
In 2009, we established the “Sisters with a Voice” HIV
prevention and sexual and reproductive health services for
FSW in Harare, Zimbabwe, within the National Behaviour
Change Programme.11 Since then, the “Sisters” program has
expanded across the country and provides free access to HIV
testing, STI treatment, family planning, HIV prevention
education, condoms, and legal services.12 There are 6 ﬁxed
sites in larger towns or cities open on weekdays, with mobile
teams providing once weekly clinical services to surrounding
hotspots or smaller towns (outreach services). The program is
supported by trained peer educators and community mobili-
zation and empowerment activities. Peer educators and out-
reach staff run participatory group meetings with sex workers
at all sites (including outreach sites) at least once a month.
Materials to support group activities are aimed at creating
demand for services and building social cohesion and
empowerment. In the case of outreach sites, peer educators
are responsible for maintaining program activities in between
weekly program visits. Women attending the program who
are HIV negative are encouraged to retest every 6 months, but
there is no active follow-up of women who default. From
2009 to 2013, access to antiretroviral (ARV) medication
increased rapidly across Zimbabwe.13 Over this period, the
program itself did not initiate women onto antiretroviral
treatment (ART) but referred women to public services. HIV-
positive individuals were eligible to initiate ART when their
CD4 count fell below 350 cells per mL.14
Data Collection
At ﬁrst visit to the program at any site, women were
assigned a unique identiﬁer. At each visit to the program, they
were asked if they had been to the program before and if so
the ﬁle was retrieved and unique ID used to link consulta-
tions. This linkage was possible both within and across sites;
however, as discussed further below, it is possible that if
women chose to deliberately withhold the fact that they had
been previously enrolled some records may not have been
linked, so some women may appear as duplicates in the data.
Data were collected on structured forms by nursing staff
undertaking clinical consultation and subsequently single-
entered into a database in Microsoft Access. Data on HIV
tests conducted by the program were entered into a separate
data ﬁle. Sociodemographic information included date of
birth, marital status and parity, and beginning in mid-2011,
educational attainment. At all visits, information was col-
lected on whether FSW had ever tested for HIV and the date
and result of the most recent test, wherever this had been
undertaken. Among women identiﬁed as HIV infected, data
were collected at each visit on whether and when ARVs had
been initiated and if these were currently being taken. We
analyzed information from visits to all 26 sites collected
between September 11, 2009, the date of the ﬁrst visit to the
Harare clinic, and March 14, 2014, the last visit considered
for this analysis.
Data Management
Date ﬁelds were re-coded in “date” format. Dates that
were not in a valid format were checked against source data.
We speciﬁed logical queries for valid dates and the result of
HIV tests, for example, querying when a negative test was
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reported after a positive test. Some events, such as HIV tests,
could be reported at more than 1 consultation or might have
appeared both as a self-reported test and in the program
testing database. For example, if a FSW made several visits to
the program, the same last HIV test may have been reported
more than once, sometimes at different levels of precision.
We harvested the most precise information provided across
all visits and removed duplicates: for example, September
2010 would be updated by 15 September 2010. Data related
to events that occurred before ﬁrst visits to the program were
also collected. For example, the date of the ﬁrst HIV test may
have been some years in the past. In these cases, where
a precise date was not provided, we imputed the date as the
ﬁrst of the month where month and year were present and ﬁrst
January if only the year had been provided. We merged the
visit and testing database and identiﬁed and removed
duplicate HIV tests (by patient ID and date) reported in both.
Finally, we excluded women from analysis where we
remained concerned about data accuracy. Our approach was
conservative. For all events occurring on or subsequent to the
ﬁrst visit to the program, we required that full date
information (dd/mm/yyyy) was present and excluded women
with missing data in relation to these dates. Women were
excluded if they reported taking ARVs but did not report
a previous HIV-positive test; if they had an HIV-negative test
after an HIV-positive test; or if they had either an HIV test
date or ARV start date that did not have a reported month.
Figure 1 shows the ﬂow chart of exclusions. Overall, the
original database contained records on 14,143 FSW. We
excluded 808 FSW (6%) from our analysis database because
of concerns about the accuracy of data. Details of missing
data for other variables are provided with the tables. In
particular, data collection on educational attainment only
started some time after the program had been initiated.
Data Analysis
Women were assigned to 1 of 5 categories that
described them on the date of their ﬁrst visit to the program:
(1) never having HIV tested, (2) having previously tested HIV
negative over 6 months ago, (3) having previously tested HIV
negative up to 6 months ago, (4) having previously tested
HIV positive but not having commenced ARV, and (5)
having previously tested HIV positive and ever initiated
ARV treatment.
We then analyzed data on dates of visits to the program,
HIV tests, the date on which ARVs were initiated, and dates
over which FSW were aware of their HIV status. Using these
dates, we created a data set reﬂecting an open cohort of
women visiting the program. Within the data, a personal
timeline was constructed for each FSW. The “revisit rate” was
the proportion of individuals coming for more than 1 visit to
the program. We calculated the median time between ﬁrst and
second visits for those who attended at least twice. The level
of “HIV-negative status awareness” was calculated as the
proportion of time between ﬁrst and last visits to the program
during which individuals who had not previously had
a positive HIV test “knew” their HIV status to be negative.
Women were considered to “know” their HIV-negative status
if they had tested HIV negative within the previous 6 months.
The denominator time was censored if women became HIV
positive. The “ARV initiation rate” was calculated as the rate
at which women initiated ARVs among those who reported
knowing that they were HIV positive but not on ARV
therapy. The person time at risk was calculated as the time
between the ﬁrst visit where the woman reports being HIV
positive (or a positive test conducted by the program) and the
last HIV-negative visit, with censoring at the date where
women reported initiating ARV.
We calculated HIV prevalence as the number of
positive ﬁrst tests divided by the number of ﬁrst HIV tests
reported. To estimate HIV incidence, we restricted our
analysis to individuals who had or reported having at least
2 HIV tests after ﬁrst attending the program. We identiﬁed
individuals who had a positive test result and a prior negative
test since their ﬁrst visit to the program and imputed the date
of infection as the midpoint between the negative and positive
test result. These individuals contributed time at risk from
their ﬁrst visit until this imputed date of seroconversion.
Women who did not seroconvert contributed time at risk
between the ﬁrst visit and last negative test. We also
calculated the HIV incidence rate using only HIV tests
conducted by the program. Figure 2 shows graphically how
the timeline for women was constructed.
We compared “baseline” status and longitudinal in-
dicators across several categories: time periods (before and
after July 31, 2011, which was the approximate mid-date of
the period examined here), age, marital status, and educa-
tional attainment. To describe differences between groups, we
used logistic regression for binary outcome variables and
Poisson regression for rates, reporting 95% conﬁdence
intervals with robust standard errors to account for inclusion
of data from multiple sites.
Ethics approval for the analysis of program data was
obtained from the Medical Research Council of Zimbabwe
(MRCZ/A/1762) and ethics committees of University College
London (4948/001) and London School of Hygiene and
Tropical Medicine (6524). Because the data were collectedFIGURE 1. Flow chart of exclusions.
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from women as part of routine clinical care, individual
informed consent was not obtained. Data were extracted in
anonymized form from the clinical database for analysis.
RESULTS
We recorded 31,389 consultations with 13,360 women
(median age at ﬁrst visit 29 years). Most FSW attending the
program had secondary education (6889/9316, 74.0%) and
a high proportion were divorced or separated (8101/13,257,
61.1%) (Table 1). Some 28.0% (3735/13,360) had never
previously tested for HIV when they ﬁrst attended the
program; though after July 2011, this proportion was smaller
(1898/8794, 21.6%). Among those who had tested for HIV
before their ﬁrst visit, 50.4% (4847/9625) reported having
tested positive. Among those who had tested HIV positive,
41.0% (1986/4847) reported previously initiating ARV
treatment. Younger FSW (12–25 years) were the most likely
to have tested HIV negative within the previous 6 months.
Older FSW were more likely to be HIV positive and on
treatment. Divorced or widowed FSW were those most likely
to be HIV positive and on treatment.
The highest number of visits made by any individual
client was 37, and the highest number of consultations
occurred at the main clinic in Harare, which was the ﬁrst
clinic to open (12,033 consultations, 38.3% of the total).
A total of 7445 visits were by FSW who only attended the
program once (55.7% of individuals), the remainder were
follow-up visits by 5915 individuals who attended more than
once, with a mean of 4 and median of 3 visits, with 2448
(18.3%) coming twice. The median time between ﬁrst and
second visit was 53 days (lower-quartile 19, upper-quartile
126) among the 5915 women who attended twice or more.
Individuals whose ﬁrst visit was before July 2011 were more
likely to come back (Table 2). Individuals who reported being
HIV positive at baseline were more likely to re-attend (Table
2). Among those individuals who had an HIV-positive test
conducted by the program (N = 1263) and would have
therefore been referred to government services, 54.1% were
not seen again, whereas 16.0% (93/580) of those who were
seen again later reported having started ARVs.
HIV-negative FSW engaged with the program had had
a negative test within the last 6 months 26.5% of the total
follow-up time (95% CI: 23.4 to 29.5) (Table 3). Those who had
never previously tested at their ﬁrst visit to the program were the
least likely, during their engagement with the program, to know
their status (19.9% of the total follow-up time, 95% CI: 17.1 to
22.8). After July 2011, a greater proportion of women were
aware of their status: among those who ﬁrst came to the program
after July 1, 2011, FSW knew their status 30.4% of time. The
program conducted 2750 HIV tests, 1263 (45.9%) of which
were positive. 760/14,579 (5.2%) of the HIV tests took place
within 3 months of a previous negative test. Of these, 733 were
HIV negative and 27 were HIV positive.
In total, 355 individuals with an HIV-positive test
reported starting ARV therapy during 1539 person years of
follow-up (rate 23.0 initiations/100 person years of follow-up)
calculated from the ﬁrst time that the program was aware of
their HIV-positive status until either their last visit or date of
initiating ARV therapy. The ARV initiation rate increased with
participant age and was highest among individuals who arrived
having had an HIV-negative test within the previous 6 months.
Some 67 women seroconverted after their ﬁrst visit,
among the 605 women who had at least 2 tests at or after their
ﬁrst visit including at least 1 negative test, and over 686
person years of follow-up. Among these women, the rate of
new infection was 9.8 per 100 person years of follow-up
(95% CI: 7.1 to 15.9). Incidence was lower among women
aged over 35 (6.0 cases per 100 person years) and in women
who had tested for HIV within 6 months before the ﬁrst visit
(7.3 cases per 100 person years). The incidence rate
calculated using only HIV tests administered by the program
was 12.5 (95% CI: 6.9 to 21.2) per 100 person years of
follow-up (24 cases in 193 person years follow-up).
DISCUSSION
We used individual-level, anonymized data drawn from
an outreach program database to calculate indicators of HIV-
intervention uptake among women accessing an outreach
HIV prevention program for FSW in 26 sites across
Zimbabwe and estimated the rate of HIV seroconversion
among women reporting 2 or more HIV tests. Given the
complexity of HIV surveillance among FSW, and the paucity
of epidemiological data on this group in Africa, we suggest
that program data could be better harnessed to characterize
FIGURE 2. Examples of timelines of female sex-worker event
histories. This graph shows the timelines of 9 women who first
attended the clinics after January 2011. These timelines show
HIV tests (negative and positive), visits, dates of starting ART,
and approximate seroconversion dates calculated as the
midpoint between a positive test and the last negative test.
The lines connect the first and the last visits. The timelines on
the left use all HIV test data; whereas on the right, only pro-
gram tests are used. As a result, the estimated time of sero-
conversion—or the estimation of seroconversion at all—is
often different in the 2 data-handling approaches. In the
timeline labeled “A,” the seroconversion date is calculated
using a negative test before the first visit, which would not be
permitted in our primary incidence estimation procedure, and
also estimates the seroconversion date to be before the start of
follow-up, thus being excluded from all analysis.
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the epidemiology of HIV among FSW and to inform public
health action.
Establishing population-based measures of HIV-related
phenomena among FSW is difﬁcult because it is not possible
to enumerate and conduct random-sampling-based surveil-
lance.5 Our approach uses outreach program data and has
several limitations which we discuss below. However, our
analysis also had strengths. We collected longitudinal data
from a large sample of women self-identifying as FSW. As
we discuss below, these women may not be representative of
all FSW. However, our program attendees are likely to be
more representative of the underlying population than the
research cohorts of FSW among whom many studies are
conducted.10 Taken at face value, the data provide strategic
information that could guide HIV resource allocation and
programming in Zimbabwe. The data suggest very high HIV
incidence among FSW. Most FSW had previously tested for
HIV when they accessed the program. However, rates of
repeat testing were not optimal. Just over half of FSW seen by
the program did not return for a second visit, suggesting
retention could be improved. Finally, around 41% of FSW
who had previously tested positive at ﬁrst visit had also
started ARVs, whereas HIV-positive FSW started treatment at
a rate of 23/100 person years of engagement with the program
each year. Although not all FSW will be eligible at the
treatment guidelines in place during this time, this reﬂects
another area for potential strengthening: Zimbabwe’s 2013
revision of National ART guidelines recommends ART for all
HIV-positive SWs regardless of CD4 count.15
However, caution is warranted: the methods we
describe may suffer from potential biases requiring further
characterization. The most obvious limitation of data col-
lected through outreach programs is that they only offer
information on FSW accessing the program. There are several
reasons why these women may not be representative of the
wider FSW population. Those who do not access services
may be more at risk of HIV infection than those who do, for
example, their nonaccess of the program may be reﬂective of
riskier, more unstable lifestyles. Conversely, those accessing
services may have higher risk than the underlying population
of FSW: for example, individuals may be likely to attend
services if they suspect recent exposure to HIV infection or
have become sick. Further, although those who attended these
outreach services may be more likely to access health care
and stay engaged with services, they may not be. We have
limited data on the rate with which FSW accessed other
clinics or private services. Some FSW who did not access the
outreach program were likely accessing the same services
through other channels. Indeed, over 70% of the FSW
attending the program had previously had an HIV test before
their ﬁrst engagement with our program and among those
presenting with a prior HIV-positive test 41% had already
initiated ARV. Further, the characteristics of FSW who access
the program may also change over time. The balance of these
factors inﬂuencing who does and does not appear among the
recruited sample is hard to gauge. These limitations notwith-
standing uncertainties about representativeness also affect all
other approaches to surveying FSW, such as RDS surveys.
TABLE 1. Sociodemographic Characteristics at First Visit of Women Accessing Dedicated FSW STI and HIV Prevention Services in
26 Sites in Zimbabwe, 2009–2012
Total
Never Tested at
First Visit
Previous
HIV-Negative
Test .6 mo Ago
HIV-Negative
Test ,6 mo Ago
Previous Positive Test,
Not on Treatment
Previous Positive Test,
and on Treatment
n Col (%) n Row (%s) n Row (%s) n Row (%s) N Row (%s) n Row (%s)
Total 13,360 100 3735 28.0 2348 17.6 2430 18.2 2861 21.4 1986 14.9
Period of ﬁrst visit
Before July 1, 2011 4566 34.2 1837 40.2 683 15.0 497 10.9 1015 22.2 534 11.7
After July 1, 2011 8794 65.8 1898 21.6 1665 18.9 1933 22.0 1846 21.0 1452 16.5
Age Col (%) Col (%) Col (%) Col (%) Col (%)
12–25* 3815 29.1 1158 31.5 856 37.1 1075 45.3 577 20.6 149 7.7
26–35 5941 45.3 1661 45.1 1026 44.5 945 39.8 1473 52.6 836 43.0
36+ 3350 25.6 863 23.4 424 18.4 355 15.0 748 26.8 960 49.4
Education
None/Primary 2427 26.1 571 27.4 378 21.5 409 20.5 574 29.1 495 33.0
Secondary 6889 74.0 1517 72.7 1377 78.5 1589 79.5 1402 71.0 1004 67.0
Marital Status
Cohabiting/Married 351 2.7 82 2.2 86 3.7 76 3.2 61 2.2 46 2.3
Divorced/Separated 8101 61.1 2290 61.8 1477 63.4 1603 66.4 1730 61.0 1001 50.8
Never married 2172 16.4 681 18.4 472 20.3 475 19.7 344 12.1 200 10.2
Widowed 2633 19.9 655 17.7 296 12.7 260 10.8 699 24.7 723 36.7
Four thousand forty-four women have missing education data, 224 have missing age data, and 103 have missing marital status. Missingness in education is largely due to education
not having been collected before 2011 (missing in period 1 = 3773, missing in period 2 = 271). The proportion HIV positive at ﬁrst visit, by age group, was 19.0% (726/3815)
for 12–25 years; 38.9% (2309/5941) for 26–35 years; and 51.0% (1708/3350) for 36+ years. The proportion who had started ART at ﬁrst visit, by age group, was 3.9% (149/3815) for
12–25 years; 14.1% (836/5941) for 26–35 years; and 28.7% (960/3350) for 36+ years. Note that over the period of the analysis, HIV+ women with a CD4 count of ,350 cells/were
eligible for ART.
*Although the youngest FSW age recorded in our database is 12 years, in total there were 115 FSW who reported an age under 18 years, and a further 450 aged 18–19 years.
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Another potential limitation is that although we issued
each woman with a unique identiﬁer code that could be used
to identify her at future visits to the program at any site, this
system involved no biometrics or validation and it is likely
that some individual women appear as duplicates in the data
set. FSW working in Zimbabwe are highly mobile and may
access the program at multiple sites. A further limitation with
respect to our calculation of HIV incidence is that we
incorporate information on the self-reported results of HIV
tests. We used a longitudinal approach, incorporating data
from self-reported data on HIV tests in the context of a clinical
interview, as opposed to household interviews which may be
more prone to reporting bias. Many tests were conﬁrmed
through the program. Although much less precise, our
incidence estimate using only tests actually conducted by
the program was very similar to our estimate using all
reported tests after the ﬁrst visit.
There are limited data on HIV and service access
among FSW in sub-Saharan Africa with which to compare
our data. With respect to epidemiological parameters, our
estimate that 50% of FSW who had previously tested at ﬁrst
visit were HIV positive is in line with our own estimates of
HIV prevalence from RDS surveys in 3 sites in 2011 (50%–
70%)4 and in 14 sites in 2013 (mean 56%).16 Global estimates
of FSW HIV prevalence suggest that this is much higher than
in the general population1; in Zimbabwe, general population
HIV prevalence for women aged 15–49 is 15%.17 There are
little comparable data for FSW HIV incidence from any
setting in sub-Saharan Africa,18–21 whereas general population
HIV incidence in Zimbabwe is estimated at about 1% per
annum.22 We estimate a ﬁgure of 10–12 times higher than this
among FSW accessing a dedicated HIV prevention program
and reporting multiple HIV tests. Approximately 70% of our
sample had ever tested for HIV at their ﬁrst visit to the
program, 60% before July 2011 and 78% after. Among the
general population in the 2010/11 Zimbabwe Demographic
Health Survey, 57% of all women aged 15–49 had ever
tested, up from 22% in 2005/6 and with higher rates among
those aged 20–49 (,2% of the program attendees were aged
below 20).17 Data from 2008–2010 suggest that 60% of FSW
in sub-Saharan Africa had tested in the last 12 months.23 HIV
testing is available to FSW, even in the absence of targeted
services, though there are signiﬁcant barriers to service access
in our setting24 and in others.25 Our estimate that at ﬁrst visit
to the program, 41% of HIV-positive FSW were on ARV is
similar to the 38% ﬁgure reported in a recent systematic
review.10 Overall, data obtained from this program platform
seem compatible with other information currently available
on FSW.
Many programs collect data from clients to support
service delivery. In turn, aggregated data are often reported to
funders or regulatory bodies. However, these statistics often
do not reﬂect the depth of analysis that may be possible. We
used standard epidemiological techniques to generate a virtual
open cohort of women accessing the program and generated
a range of useful statistics. The approaches we used are not
complex though they require care in both data collection
and analysis. We advise other programs to consider this
TABLE 2. Proportion of Women Re-Attending Within 12 Months of First Visit (Women Who First Visit After 15/03/2013 Excluded)
Total n (Col %) n Row (%)
Unadjusted
Odds Ratio (95% CI) P (LRT)
Adjusted
Odds Ratio (95% CI) P (LRT)
Total 9540 4622 48.5
Period of ﬁrst visit
Before July 1, 2011 4566 (47.9) 2432 53.3 Baseline Baseline
After July 1, 2011 4974 (52.1) 2190 44.0 0.69 (0.57–0.84) ,0.001 0.81 (0.69–0.95) 0.010
Age
12–25 2688 (28.4) 1174 43.7 Baseline
26–35 4318 (45.6) 2161 50.1 1.29 (1.20–1.39)
36+ 2472 (26.1) 1273 51.5 1.37 (1.21–1.55) ,0.001
Education
None/Primary 1442 (25.7) 637 44.2 Baseline Baseline
Secondary 4166 (74.3) 1861 44.7 1.02 (0.88–1.18) 0.79 1.05 (0.93–1.20) 0.41
Marital Status
Cohabiting/Married 161 (1.7) 77 47.8 0.97 (0.77–1.22) 0.90 (0.72–1.12)
Divorced/Separated 5808 (61.1) 2767 47.6 0.96 (0.89–1.03) 0.88 (0.80–0.97)
Never married 1519 (16.0) 739 48.7 Baseline Baseline
Widowed 2017 (21.2) 1020 50.6 1.08 (0.93–1.25) 0.13 0.91 (0.77–1.08) 0.013
Baseline status
Never tested 3147 (33.0) 1277 40.6 Baseline Baseline
Previous HIV2 .6 mo ago 1584 (16.6) 727 45.9 1.24 (1.05–1.47) 1.40 (1.23–1.59)
HIV2 within 6 mo 1497 (15.7) 767 51.2 1.54 (1.39–1.70) 1.87 (1.70–2.06)
HIV+ and not on treatment 2076 (21.8) 1130 54.4 1.75 (1.58–1.93) 1.64 (1.37–1.98)
HIV+ and on treatment 1236 (13.0) 721 58.3 2.05 (1.86–2.25) ,0.001 2.06 (1.76–2.41) ,0.001
Odds ratios estimated using logistic regression with robust standard errors. Association with education and marital status adjusted for age; association with baseline status adjusted
for age, education, and marital status. The association between period and return visits within 6 months was adjusted for by all the other variables.
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TABLE 3. Longitudinal Knowledge of HIV Status Among HIV-Negatives; Rate of Starting Antiretroviral Medication Among
HIV-Positives; HIV Incidence
% of Time Engaged in Care “Knowing
Status” Among Those Who Arrive
HIV 2ve Rate of Starting ARV
N (Col %) PY/Total PY
Mean Proportion (%)
(95% CI) N (Col %) n/100PY Rate/100 PY Rate Ratio (95% CI)
Total 2882 649/1935 26.5 (23.4–29.5) 2145 354/15.4 23.0 (19.3–26.9)
Period of ﬁrst visit
Before July 1, 2011 1233 (42.8) 326/1077 21.2 (19.2–23.1) 1145 (53.4) 237/10.6 22.4 (19.8–27.0) Baseline
After July 1, 2011 1649 (57.2) 323/858 30.4 (25.6–35.2) 1000 (46.6) 117/4.8 24.3 (14.3–42.7) 1.08 (0.70–1.71)
Age
12–25 1029 (36.0) 230/656 28.6 (25.2–32.1) 461 (21.6) 41/3.3 12.3 (9.2–16.2) Baseline
26–35 1233 (43.1) 281/869 24.8 (22.3–27.3) 1138 (53.3) 196/8.2 23.9 (17.9–30.1) 1.94 (1.47–2.55)
36+ 598 (21.9) 135/403 26.3 (22.2–30.3) 536 (25.1) 116/3.8 30.4 (27.6–35.1) 2.47 (1.87–3.25)
Education
None/Primary 409 (22.7) 81/208 30.0 (24.6–35.4) 321 (28.0) 44/1.6 28.1 (14.2–61.2) Baseline
Secondary 1394 (77.3) 287/772 30.3 (25.7–34.9) 824 (72.0) 96/4.5 21.3 (14.1–32.5) 0.76 (0.51–1.12)
Marital Status
Cohabiting/Married 82 (2.9) 16/48 24.6 (16.8–32.3) 43 (2.0) 7/0.3 24.4 (8.4–61.1) 1.38 (0.49–3.85)
Divorced/Separated 1802 (62.9) 412/1219 27.2 (23.5–31.0) 1298 (61.0) 218/9.6 22.7 (18.1–28.1) 1.28 (0.84–1.94)
Never married 568 (19.8) 120/363 27.4 (23.4–31.4) 293 (13.8) 36/2.0 17.8 (11.1–26.9) Baseline
Widowed 414 (14.5) 95/293 22.2 (17.6–26.8) 495 (23.3) 92/3.4 26.9 (23.0–30.6) 1.52 (0.96–2.41)
Baseline status
Never tested 1022 (35.5) 170/664 19.9 (17.1–22.8) 509 (23.7) 89/3.3 26.8 (20.0–45.7) Baseline
HIV .6 mo ago 835 (29.0) 201/563 29.5 (26.2–32.9) 138 (6.4) 20/0.8 25.4 (16.1–40.1) 0.95 (0.62–1.44)
HIV2 within 6 mo 1025 (35.6) 277/708 30.5 (26.0–34.9) 47 (2.2) 7/0.2 31.4 (17.6–55.6) 1.17 (0.64–2.14)
HIV+ and not on treatment N/A 1451 (67.7) 238/11.1 21.5 (16.4–26.7) 0.80 (0.58–1.11)
HIV Incidence (Seroconversion Date Estimated with Tests after First Visit Only)
N (Col %) n/100 PY Rate Per 100 PY Rate Ratio (95% CI)
Total 605 67/6.9 9.8 (7.1–15.9)
Period of ﬁrst visit
Before July 1, 2011 293 (48.4) 45/4.3 10.5 (8.0–16.0) Baseline
After July 1, 2011 312 (51.6) 22/2.6 8.6 (4.9–18.5) 0.82 (0.51–1.32)
Age
12–25 223 (37.0) 27/2.5 10.8 (8.1–16.1) Baseline
26–35 262 (43.5) 32/3.0 10.7 (6.8–22.1) 0.99 (0.76–1.29)
36+ 118 (19.6) 8/1.3 6.0 (3.6–10.1) 0.56 (0.36–0.87)
Education
None/Primary 77 (21.5) 4/0.7 5.7 (2.3–14.8) Baseline
Secondary 282 (78.6) 28/2.5 11.3 (7.5–18.4) 1.97 (0.85–4.57)
Marital Status
Cohabiting/Married 14 (2.3) 1/0.1 7.3 (N/A–N/A) 0.79 (0.09–7.04)
Divorced/Separated 394 (65.7) 50/4.4 11.3 (8.3–17.4) 1.22 (0.63–2.36)
Never married 108 (18.0) 11/1.2 9.2 (4.8–24.2) Baseline
Widowed 84 (14.0) 5/1.0 4.8 (2.9–10.3) 0.52 (0.26–1.04)
Baseline status
Never tested 159 (26.3) 23/1.9 11.9 (8.7–17.9) Baseline
HIV .6 mo ago 195 (32.2) 24/2.2 11.0 (6.9–20.8) 0.93 (0.57–1.50)
HIV2 within 6 mo 251 (41.5) 20/2.8 7.3 (4.9–13.4) 0.61 (0.43–0.87)
HIV+ and not on treatment N/A N/A
All 95% conﬁdence intervals are robust to clustering. Extent of engagement with care, shown for women who arrive HIV-negative in terms of the amount of time knowing their
HIV status (ie, having been recently tested), and as the rate of uptake of ART for HIV-positive women. Seroconversion date estimated as the midpoint between positive test and last
HIV-negative test. Follow-up time from ﬁrst to last HIV-negative test, or seroconversion date. The incidence of HIV calculated from program tests only was 12.5 (robust 95% CI: 6.9 to
21.2), resulting from 24 cases and 193 person years.
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possibility. In 2014, we established an electronic data capture
platform that has now been rolled out in all sites. Data are
uploaded in real time. This system will improve data
completeness, quality, and participant tracking. In future
work, we plan to compare the population accessing the
program with data from 14 RDS surveys in overlapping sites
and plan to explore geographical and over-time variation in
the indicators. These analyses will be used where possible to
guide and strengthen program implementation, for example
by identifying where testing activities might be strengthened,
and to provide information for policy makers to inform
resource allocation decisions. Finally, the data will be
leveraged to provide process indicators for an ongoing
cluster-randomized trial: the “Sisters antiretroviral therapy
program for prevention of HIV: an Integrated response”
(SAPPH-IRE) intervention trial (PACTR201312000722390).
The combination intervention under study in the trial seeks to
improve the accessibility of ARV for both prevention and
treatment for FSW in Zimbabwe: the program data platform
will provide data on whether the intervention has succeeded
in improving retention, as well as rates of repeat testing and
linkage to ART treatment and prevention.
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